Vortioxetine (5, 10, 15, 20) mg

Vortioxetine, a novel antidepressant belongs to the “Other Antidepressants” class, vortioxetine is an antidepressant with a multimodal mechanism of action that combines modulation of 5-HT receptor activity with inhibition of the SERT.

• Vorasan is an effective initial and maintenance treatment for major depressive disorder patients (MDD).
• Vorasan is the first and only antidepressant that improves cognitive function associated with daily functioning at work, home and socially.
• Vorasan improves all the multiple symptoms of MDD including physical, cognitive and mood symptoms.
• Vorasan achieved the best balance between efficacy and tolerability.
• Vorasan achieves superior response and remission rates in patients who had a partial response to an SSRI or SNRI.
• Vorasan does not exhibit many side effects as typical SSRIs and SNRIs such as sexual dysfunction, weight gain, and sleep disturbances.
• Vorasan does not affect driving performance.
• Vorasan can be stopped abruptly, without the need for gradual dose reduction due to its long half-life (66 hours).
• Vorasan is given once daily without regard to food and at any time of the day